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a b s t r a c t
Trophectoderm cell lines were established from 8-day in vitro-cultured embryos of cat-
tle derived from fertilization (IVF), somatic cell nuclear transfer (NT), or parthenogenetic
activation (P) of in vitro-matured oocytes and from five 8-day-old in vivo (V) embryos.
The most abundant cellular proteins of 5 V-, 16 NT-, 12 P-, and 16 IVF-derived cell lines
were compared by 2D-gel electrophoresis and mass spectrometry; that is, the unaltered
thiourea/urea extract of each cell culture was analyzed. Common protein spots (n=118)
were examined, and 95% were identified with significant scores from protein and gene
database searches. Of the proteins detected and identified, actin and cytokeratin-8 were
found to be themost abundant. Other prominent cellular proteinsweremetabolic enzymes
such as aldose reductase, phosphoglycerate mutase, enolase, triosephosphate isomerase,
cytoskeletal interacting proteins transgelin and stratifin, anti-oxidant proteins peroxire-
doxin 1 and anti-oxidant protein 2, and the calcium-dependent lipid-binding proteins
annexins I and II. In comparative analysis of the 2D-gels, the NT-derived trophectoderm
had less annexins I and II in comparison to the IVF- and P-derived trophectoderm. Because
annexins I and II are abundant in the placenta and have functions important to the main-
tenance of placentation, the down-regulation of the annexin genes in the cultured NT
trophectoderm may be related to the frequent failures of NT pregnancies.
Published by Elsevier B.V.
1. Introduction
Animal cloning by somatic cell nuclear transfer (NT)
was first demonstrated in ungulates (Wilmut et al., 1997;
Cibelli et al., 1998) and is a promising technology with the
potential for increasing the efficiency of making precise
modifications to themammalian genome.However, as cur-
rently practiced90–98%ofNTembryos are lost in utero, and
∗ Corresponding author at: USDA, ARS, ANRI, ABBL, Bldg. 200, Rm. 13,
BARC-East, Beltsville, MD 20705-2350, United States.
Tel.: +1 301 504 8216; fax: +1 301 504 8414. .
E-mail address: neil.talbot@ars.usda.gov (N.C. Talbot).
at least 20%of offspring resulting fromNTexperience lethal
developmental abnormalities (De Sousa et al., 2001; Hill et
al., 1999, 2000, 2002). Thus, the incidenceof pregnancy fail-
ure and developmental abnormalities in NT cattle reduces
the effectiveness of NT as ameans of genetic improvement.
The gene expression of embryos and fetuses produced
by normal fertilization with sperm in comparison with
embryos produced by NT shows numerous differences
(Wrenzycki et al., 2001;Nowak-Imialeketal., 2008;Perecin
et al., 2009). Conservation of appropriate DNA methyla-
tion patterns appears to be a problem in NT embryos
(Bourc’his et al., 2001; Kang et al., 2002; Cezar et al., 2003;
Santos et al., 2003). Histones and other DNA accessory
proteins which control the form and function of the chro-
0378-4320/$ – see front matter. Published by Elsevier B.V.
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matin are also changed as a result of NT (Tamada et al.,
2006; Laurincik and Maddox-Hyttel, 2007). This incom-
plete “nuclear reprogramming” that results in the loss of
normal epigenetic modifications to the DNA may be the
major cause of the developmental failures of NT embryos
(Surani, 2001; Humpherys et al., 2001).
Among the most common of the developmental abnor-
malities that arise from NT reprogramming errors are
deficiencies in placentation or placental hyperplasia (Hill
et al., 2000; Tanaka et al., 2001). The failure to form a
normal placenta may be responsible for many NT preg-
nancy losses in cattle (Hill et al., 2000; De Sousa et al.,
2001; Hashizume et al., 2002; Lee et al., 2004; Patel et
al., 2004). The trophectoderm is the embryonic tissue that
mediates placental connections with the uterine epithe-
lium, and it was recently reported that DNA methylation
anomalies were specifically localized to this tissue in NT
cattle embryos (Kang et al., 2002). Also, changes in the
expressionofkeysecretoryproteinsof trophectodermhave
been found inNT embryos of cattle (Wrenzycki et al., 2001;
Talbot et al., 2008). The analysis of trophectoderm cells
might therefore be useful in determining epigenetic defi-
ciencies that lead to placental dysfunction in NT cattle.
Cellular proteins of IVF-, parthenogenote-, NT-, and in
vivo-derived cattle embryos were compared using tro-
phectoderm cell lines derived from each type of embryo.
The use of cell lines enabled the production of relatively
large amounts of embryo-specific and tissue-specific sam-
ple protein that would otherwise have been very limited
due to the small size of 8-day in vitro-cultured cattle
embryos. Two-dimensional gel (2D-gel) analysis and mass
spectroscopy were applied to determine the profiles of
the most abundant proteins in the cultured trophecto-
derm cells. Among these, at least two proteins, annexin I
and annexin II, were found to be down-regulated in the
NT-derived trophectodermcell lines. Thepotential involve-
ment of annexin expression and function in NT pregnancy
failure of cattle is discussed.
2. Materials and methods
2.1. Cell culture and reagents
All cells were grown on 25 cm2 tissue culture flasks
(T25; Greiner, Frickenhausen, Germany). Fetal bovine
serum (FBS) was purchased from Hyclone, Logan UT.
Cell culture reagents were purchased from InVitrogen,
Gaithersburg, MD. Trophectoderm cells were grown on
irradiated STO mouse fibroblast (CRL 1503, American
Type Culture Collection, Rockville, MD) feeder cell layers.
Feeder-layers were prepared by exposing a suspension of
STO cells to 8Krad of gamma radiation and plating the cells
at 6×104 cells/cm2. STO feeder-layers were maintained by
refeeding every 6–7 days with DMEM supplemented with
4mM l-glutamine and10%FBS (10%DMEM). Cultureswere
routinely maintained at 37 ◦C and in a 5% CO2 atmosphere.
2.2. Trophectoderm cell line establishment
In vitro-produced (IVP) blastocysts of cattle derived
from either in vitro maturation, fertilization, and culture
(IVF), or somatic cell nuclear transfer (NT), or partheno-
genetic activation (P) were produced from oocytes
obtained from slaughter house ovaries as previously
described (Powell et al., 2004; Talbot et al., 2007a,
2008). Blastocysts of good morphological quality were
used to establish trophectoderm cell lines. Briefly, in vivo
blastocyst-derived cell lines were established from 8-day
“hatched” blastocysts with clearly visible ICMs, obtained
after artificial insemination (AI) as previously described
in Talbot et al., 2007a. For the AI, sperm collected from
a F1 transgenic Jersey bull was used (Powell et al., 2004;
Talbot et al., 2007a). For NT, IVF, and P cell lines, the blas-
tocysts used were from 8 to 11 days of culture, with the
majority being from 8 to 9 days of culture. IVF blasto-
cysts had usually “hatched” from their zona pellucida. The
zona pellucida of parthenogenetic embryoswas rarely rup-
tured by 8 or 9 days of culture so the trophectoderm cell
lines were usually started from expanded blastocysts with
a very thin zona pellucida. Most of the NT blastocysts had
protruded through the slit in the zona pellucida made by
the enucleation micropipette, and they therefore formed a
typical dumbbell-shaped “hatching” blastocyst. NT blasto-
cysts were produced from two bovine fetal fibroblast cell
lines as the nuclear donor source, and two of the three
GFP expressing NT trophectoderm cell lines were colony-
cloned 2 times in order to produce a population of cells
that were 100% GFP expressing (see Table 1). To estab-
lish blastocyst-derived bovine trophectoderm cell lines,
whole blastocysts were culture on STO feeder cells for 2–3
weeks and primary trophectoderm outgrowths were iden-
tified and isolated as previously described (Talbot et al.,
2000, 2007a, 2008). Primary trophectoderm colonies were
passaged to T25 flasks of STO feeder cells by physical disag-
gregation andwere similarly passaged for 3–12more times
until established as cell lines, i.e., showed uniform growth
(Talbot et al., 2000). The bovine trophectoderm cell lines
were designated according to the source blastocysts, i.e.,
IVF blastocyst-derived cell lines were designated, FT-, NT-
derived cell lines, NT-, P-derived cell lines, PT-, and in vivo
blastocyst-derived cell lines, VIVOT.
2.3. Two-dimensional gel electrophoresis of cellular
proteins
Cellular proteinswere extracted froma single T25 tissue
culture flask where the cells had reached 75–100% con-
fluency. Generally the period of time to reach this level
of confluency was 1–2 weeks post-passage, but some cul-
tures, particularly at earlier passage levels, were grown
for up to 3 weeks before harvesting for protein. The cul-
ture medium was removed by aspiration and flasks were
washed 4 times with ice cold 0.25M sorbitol solution
(4–5ml). The final sorbitol wash was drained well and
thoroughly aspirated, and the flasks were immediately
frozen and stored at −70◦ C. Flasks were thawed and 1ml
of lysis buffer (7M urea, 2M thiourea, 50mM DTT, 4%
CHAPS, 0.5% Bio-Lytes) was added to each flask which was
incubated on ice for 20min. Cells were scraped and dis-
rupted by sonication. Insoluble material was removed by
centrifugation at ∼12,000× g for 20min at 22 ◦C and the
cell lysates were frozen at −80◦ C. The first dimension
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Table 1
Biological origins of nuclear transfer-derived trophectoderm cell lines.
Cell line name Nuclear donor
cell line
aOocyte
source
Passage
tested
Comments
NT2-5 BFF-10 BOMED P2 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT2-11 BFF-10 BOMED P2 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT2-16 BFF-10 BOMED P3 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT2-20 BFF-10 BOMED P2 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT6-169 BFF-10 BOMED P2 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT6-170 BFF-10 BOMED P2 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT6-173 BFF-10 BOMED P7 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT6-175 BFF-10 BOMED P8 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT6-176 BFF-10 BOMED P2 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT6-181 BFF-10 BOMED P6 2005; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT30-6 BFF-10 MOPAC P20 2003; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT30-8 BFF-10 MOPAC P5 2003; b0.5% FBS donor cell; cG1/G2 egg culture/low O2
NT30-11 BFF-10 MOPAC P5 2003; d10% FBS donor cell; cG1/G2 egg culture/low O2
GFP-CT-2 BFF-8 MOPAC P14 1998; cCR1aa medium egg culture in ambient O2; cell line not colony-cloned
GFP-CT-3A1 BFF-8 MOPAC P8 1998; cCR1aa medium egg culture in ambient O2; cell line colony-cloned 2X
GFP-CT4-A1 BFF-8 MOPAC P25 1998; cCR1aa medium egg culture in ambient O2; cell line colony-cloned 2X
a Slaughterhouse ovaries from Bomed Inc., Madison, WI (oocytes matured in transit) or Moyer Packing Co., Philadelphia, PA (oocytes matured in-house).
b Nuclear donor cells cultured in medium with 0.5% FBS (“serum-starved”) prior to NT.
c See Powell et al. (2004) and Talbot et al. (2007a).
d Nuclear donor cells cultured in medium with 10% FBS prior to NT.
isoelectric focusing was performed using 7 cm IPG strips
(pH 3–10, Bio-Rad) in the IPGphor II system (GE Health-
care, Piscataway, NJ). All IPG strips were rehydrated in
the presence of approximately ∼225g sample protein
in a total volume 125l rehydration buffer; additional
rehydration buffer contained the following: 8M urea, 4%
CHAPS, 50mM DTT, 0.5% Bio-Lytes, 0.001% bromophenol
blue. The strips were passively rehydrated for ∼14h at rt
and voltage settings for isoelectric focusing were 500V for
30min, 1000V for 30min, and 8000V maximum to a total
of approximately 7000kVh. Second dimension separations
were done as previously described (Talbot et al., 2007b) on
10% polyacrylamide gels (8× 10 cm). The proteins in the gel
were visualized by staining with Colloidal Coomassie Blue
G-250 (Gradipure®; Life Therapeutics, Frenchs Forest, Aus-
tralia) and the gel was scanned using laser densitometry
(PDSI, GE Healthcare, Piscataway, NJ). Gels were stored in
a 20% ammonium sulfate solution in seal-o-matic plastic
bags (KAPAK, Minneapolis, MN). Gel images were pro-
cessed using 2D Elite analytical software (GE Healthcare)
to enumerate and define individual spots of interest. Spot
volumes were determined using local background for sub-
traction. All spot volume and relative spot volume values
(relative to aldose reductase or relative to phosphoglycer-
ate mutase) were analyzed by GLM ANOVA (NCSS 2000,
Kaysville, UT) and significant differences were separated
by Fisher’s LSD multiple-comparison test. In each graph
(Fig. 6), mean values with different letters are different
(P<0.05). Error bars are the standard error of the means.
2.4. MALDI-TOF-MS analysis of tryptic peptides
A Voyager DE-STR MALDI-TOF mass spectrome-
ter (Applied Biosystems, Framingham, MA) operated
in positive ion reflector mode was used to analyze
tryptic peptides. Samples were co-crystallized with á-
cyanohydroxycinnamic acid (CHCA) matrix, and spectra
were acquired with 50 shots of a 337nm Nitrogen Laser
operating at 20Hz. Spectra were calibrated using the
trypsin autolysis peaks at m/z 842.51 and 2211.10 as inter-
nal standards.
2.5. MS/MS analysis of tryptic peptides
A Thermo Finnigan LCQ Deca XP plus Ion Trap mass
spectrometer was used to analyze proteins that were not
positively identified by MALDI-TOF mass spectrometry.
Peptides were separated on a reverse phase column using
a 30min gradient of 5–40% acetonitrile:water containing
0.1% formic acid. Following a survey scan from 300 to
2000Da, MS/MS spectra were acquired on the three most
abundant ions identified in the survey scan.Dynamicexclu-
sion was employed to prevent the continuous analysis of
the same ions. The raw data was processed by Sequest to
generate DTA files for database searching. The merge.pl
script from Matrix science was used to convert multiple
Sequest DTA files in to a single mascot generic file suitable
for searching in Mascot.
Protein identification was performed by searching the
NCBI non-redundant database using the Mascot search
engine (http://www.matrixscience.com), which uses a
probability based scoring algorithm. The following vari-
ables were used for database searches with MALDI-TOF
peptide mass fingerprinting data: monoisotopic mass,
25ppm mass accuracy, trypsin as digesting enzyme with
1 missed cleavage allowed, oxidation of methionine,
N-terminal pyroglutamic acid from glutamic acid or glu-
tamine as allowable variable modifications. For database
searches with MS/MS spectra the following parameters
were used, average mass, 1.5Da peptide and MS/MS mass
tolerance, peptide charge of +1, +2, or +3, trypsin as digest-
ing enzyme with 1 missed cleavage allowed, oxidation of
methionine, N-terminal pyroglutamic acid from glutamic
acid or glutamine as allowable variable modifications. Tax-
onomy was limited to mammals for both MALDI and
MS/MS ion searches. For MALDI-TOF-MS data to qualify as
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Fig. 1. Examples of trophectoderm of cattle in primary culture and
established cell lines. (A) IVF bovine blastocyst’s primary trophectoderm
outgrowth after 10 days of culture on STO feeder cells. Magnifica-
tion≈35×. Arrows indicate borders of the primary colony. (B) Bovine
trophectoderm cell line (VIVOT-199) growing in a T25 flask on STO feeder
cells at passage 15. Arrow indicates individual colony among many that
form after each physical disaggregation passage. Magnification≈20×. (C)
Phase-contrast micrograph of bovine trophectoderm cells of the in vivo-
derived VIVOT-199 cell line at 300× magnification. Note dome formation
lower right (arrows).
a positive identification, a protein’s score had to equal or
exceed the minimum significant score. Positive identifica-
tion of proteins by MS/MS analysis required a minimum
of two unique peptides, with at least one peptide having a
significant ion score.
3. Results
Fig. 1 shows the typical appearance of primary bovine
trophectoderm cultures and cell lines at low magnifica-
tion, and of the trophectoderm cells at high magnification.
As previously shown, IVF- and NT-derived primary out-
growths occur at a similar success rate, P-derived primary
outgrowths occur at a lower rate (Talbot et al., 2008).
Fig. 2. 2D-gels of the PT28-2 parthenogenetic trophectodermcell line cel-
lular proteins and of STO feeder cell cellular proteins. Annexin I, annexin
II, aldose reductase, actin, and cytokeratin 8 are indicate in the PT28-2
gels. Loading was more than 6-fold that present in trophectoderm cell
line samples for the STO feeder cell sample.
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Table 2
Trophectoderm abundant cellular proteins of cattle identified by MALDI-TOF and LC–MS/MS.
Spot
ID #
MW PI Protein ID aPeptides
matched
bSequence
coverage
cMowse
score
dExpected
value
NCBI Method
31 41,664 5.15 Chain A,
beta-actin–profilin
complex [Bos taurus]
9 29% 89 0.00068 gi|2624850 MALDI
33 47,266 8.6 Creatine kinase,
mitochondrial 1
(ubiquitous) [Bos
taurus]
15 29% 119 6.10E−07 gi|73587293 MALDI
34 35,791 8.67 Heterogeneous nuclear
ribonucleoproteins
A2/B1 (hnRNP
A2/hnRNP B1) isoform
7 [Bos taurus]
13 46% 111 3.90E−06 gi|76662749 MALDI
35 27,686 8.87 Galectin-3
(galactose-specific
lectin 3) [Bos taurus]
8 28% 111 3.90E−06 gi|76668658 MALDI
36 18,730 8.22 Cofilin 1 (non-muscle)
[Homo sapiens]
3 19% 203 gi|15147369 MS/MS
37 53,552 5.7 Keratin 8 [Bos taurus] 29 50% 307 1.00E−25 gi|75812916 MALDI
38 47,639 6.37 Enolase 1 [Bos taurus] 11 27% 132 3.30E−08 gi|87196501 MALDI
39 27,946 4.65 Stratifin [Ovis aries] 11 37% 78 0.0051 gi|3249019 MALDI
40 36,319 5.76 Aldose reductase (EC
1.1.1.21) [Bos taurus]
8 21% 312 gi|113594 MS/MS
41 38,873 6.92 Annexin A2 [Bos taurus] 23 58% 233 1.40E−18 gi|27807289 MALDI
44 39,411 8.45 (Muscle-type aldolase)
isoform 2 [Bos taurus]
11 35% 107 1.00E−05 gi|76653611 MALDI
45 35,714 8.52 Glyceraldehyde-3-
phosphate
dehydrogenase [Bos
taurus]
6 20% 62 0.03 G3P BOVIN MALDI
47 38,927 6.37 Annexin I [Bos taurus] 12 35% 144 2.10E−09 gi|73853762 MALDI
48 29,096 6.41 Carbonic anhydrase II
[Bos taurus]
9 37% 116 1.30E−06 gi|30466252 MALDI
52 22,412 8.39 Transgelin 2 [Bos
taurus]
11 49% 133 2.50E−08 gi|61888874 MALDI
53 58,792 5.09 Keratin 10 [Homo
sapiens]
15 29% 81 0.0039 gi|40354192 MALDI
54 17,727 8.37 Peptidyl-prolyl
cis-trans isomerase A
(EC 5.2.1.8) (PPIase A)
(rotamase A)
(cyclophilin A)
(cyclosporin A-binding
protein) [Bos taurus]
7 44% 108 7.50E−07 PPIA BOVIN MALDI
56 28,802 6.67 Phosphoglycerate
mutase 1 (brain)
[Homo sapiens]
12 50% 79 0.0062 gi|38566176 MALDI
57 26,673 6.45 Triosephosphate
isomerase [Bos taurus]
11 44% 80 0.0048 gi|61888856 MALDI
58 25,051 6 Anti-oxidant protein 2
(non-selenium
glutathione
peroxidase, acidic
calcium-independent
phospholipase A2) [Bos
taurus]
10 45% 99 6.10E−05 gi|27807167 MALDI
59 22,665 5.77 Heat shock 27kDa
protein 1 [Bos taurus]
14 54% 199 6.40E−15 gi|71037405 MALDI
60 22,195 8.59 Peroxiredoxin-1 [Bos
taurus]
13 40% 188 8.00E−14 gi|66773956 MALDI
75 67,863 7.56 Transketolase [Bos
taurus]
12 20% 127 1.10E−07 gi|51491841 MALDI
76 54,939 6.51 Protein
disulfide-isomerase
(EC 5.3.4.1) ER60
precursor [Bos taurus]
26 50% 276 1.40E−22 gi|1083063 MALDI
77 42,369 5.13 Cytokeratin 8 (370 AA)
[Bos taurus]
28 70% 318 8.80E−27 gi|481 MALDI
192 N.C. Talbot et al. / Animal Reproduction Science 120 (2010) 187–202
Table 2 (Continued )
Spot
ID #
MW PI Protein ID aPeptides
matched
bSequence
coverage
cMowse
score
dExpected
value
NCBI Method
78 47,736 4.7 Tubulin, beta
polypeptide [Homo
sapiens]
17 35% 129 7.00E−08 gi|57209813 MALDI
78 51,397 4.97 Chain E, bovine
F1-ATPase [Bos taurus]
15 44% 108 8.80E−06 gi|3660252 MALDI
79 38,852 6.17 Gelsolin-like capping
protein [Bos taurus]
9 25% 90 0.00062 gi|30466254 MALDI
80 37,591 5.89 Galactose mutarotase
(aldose 1-epimerase)
[Bos taurus]
10 34% 80 0.0062 gi|77736588 MALDI
81 43,858 4.92 Cytokeratin 19 [Bos
taurus]
24 67% 306 1.40E−25 gi|62751472 MALDI
82 32,846 4.69 Tropomyosin 1-alpha
chain isoform 5 [Homo
sapiens]
22 47% 175 1.80E−12 gi|27597085 MALDI
83 28,505 4.65 Tropomyosin alpha-4
chain (tropomyosin-4)
(platelet beta
tropomyosin)
18 43% 168 8.80E−12 gi|20178270 MALDI
84 28,965 6.4 Chain A, carbonic
anhydrase II [Bos
taurus]
7 32% 104 2.20E−05 gi|46016008 MALDI
85 23,598 6.89 Glutathione-S-
transferase pi [Bos
taurus]
5 39% 70 0.051 gi|29135329 MALDI
86 20,714 6.62 Phosphatidylethanolamine
binding protein [Bos
taurus]
8 58% 87 0.0011 gi|4389366 MALDI
87 55,199 8.27 Chain A, mitochondrial
F1-atpase [Bos taurus]
15 41% 89 0.00065 gi|1943080 MALDI
88 54,751 6.55 Fascin homolog 1,
actin-bundling protein
[Bos taurus]
10 27% 111 4.40E−06 gi|78045491 MALDI
89 62,442 6.08 Hypothetical protein
LOC617109 [Bos taurus]
28 44% 170 5.60E−12 gi|78369310 MALDI
90 69,278 5.82 Albumin [Bos taurus] 14 22% 111 4.30E−06 gi|30794280 MALDI
91 73,696 5.97 Heat shock 70kDa
protein 9B (mortalin-2)
[Bos taurus]
26 47% 206 1.40E−15 gi|77735995 MALDI
93 89,274 5.13 Hypothetical protein
LOC507345 [Bos taurus]
35 41% 178 8.60E−13 gi|77735541 MALDI
94 92,369 4.76 Tumor rejection
antigen (gp96) 1 [Bos
taurus]
34 38% 218 8.60E−17 gi|27807263 MALDI
95 36,764 5.3 Annexin A8 [Bos taurus] 18 52% 214 2.20E−16 gi|27806317 MALDI
96 32,006 5.92 Purine nucleoside
phosphorylase [Bos
taurus]
11 46% 84 0.0019 gi|61553356 MALDI
97 62,027 5.14 Keratin 9 [Homo
sapiens]
16 26% 100 6.10E−05 gi|55956899 MALDI
99 12,3787 5.58 Predicted: similar to
vinculin isoform
meta-VCL isoform 1
[Bos taurus]
15 17% 72 0.036 gi|119918578 MALDI
100 57,230 4.8 Procollagen-proline,
2-oxoglutarate
4-dioxygenase [Bos
taurus]
19 37% 239 6.80E−19 gi|27806501 MALDI
102 37,687 5.43 Cathepsin D {EC
3.4.23.5} [Bos taurus]
11 30% 101 4.40E−05 gi|299522 MALDI
103 35,971 8.67 Heterogenous nuclear
ribonucleoprotein
A2/B1 [Mus musculus]
17 52% 170 5.50E−12 gi|3329498 MALDI
105 30,821 8.82 Voltage-dependent
anion channel 1 [Bos
taurus]
14 53% 121 4.40E−07 gi|73853754 MALDI
106 38,327 8.09 GNB2L1 protein [Bos
taurus]
5 10% 242 gi|74354951 MS/MS
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Table 2 (Continued )
Spot
ID #
MW PI Protein ID aPeptides
matched
bSequence
coverage
cMowse
score
dExpected
value
NCBI Method
107 30,329 8 Voltage-dependent
anion channel 2 [Homo
sapiens]
5 19% 68 0.052 gi|57209199 MALDI
108 35,935 4.86 Annexin V=CaBP37
isoform [Bos taurus]
21 64% 207 1.10E−15 gi|260138 MALDI
109 28,193 5.2 Predicted: similar to
cytoplasmic beta-actin
isoform 2 [Macaca
mulatta]
8 31% 94 0.00023 gi|109119055 MALDI
110 27,696 4.73 Tyrosine 3-
monooxygenase/tryptophan
5-monooxygenase
activation protein, zeta
polypeptide [Homo
sapiens]
14 55% 114 2.20E−06 gi|68085578 MALDI
111 33,716 5.26 Beta-actin [Lama
glama]
7 29% 64 0.2 gi|29603621 MALDI
112 31,774 4.84 Laminin-binding
protein [Homo sapiens]
4 16% 290 gi|34234 MS/MS
112 30,919 4.71 B23 nucleophosmin
(280 AA) [Homo
sapiens]
7 15% 259 gi|825671 MS/MS
113 32,356 5.28 Acidic ribosomal
phosphoprotein PO
[Bos taurus]
10 37% 83 0.003 gi|2293577 MALDI
114 33,720 6.02 Capping protein (actin
filament) muscle
Z-line, beta [Bos taurus]
6 13% 68 0.087 gi|28603770 MALDI
115 88,14 6.67 Chain B, E-trypsin
(E.C.3.4.21.4) [Sus
scrofa]
3 46% 44 20 gi|999627 MALDI
116 22,118 6.58 Biliverdin reductase B
(flavin reductase
(NADPH)) [Bos taurus]
7 43% 78 0.0089 gi|27806297 MALDI
117 69,190 5.88 ALB protein [Bos
taurus]
9 14% 61 0.47 gi|74267962 MALDI
118 19,525 4.9 Translationally
controlled tumor
protein (TCTP)
7 46% 71 0.04 gi|6175056 MALDI
119 19,635 4.71 Myosin: regulatory
light chain
8 51% 117 1.10E−06 gi|228542 MALDI
121 23,196 8.62 Peroxiredoxin 5
precursor [Bos taurus]
7 34% 72 0.036 gi|27807445 MALDI
122 17,127 6.13 Ubiquitin-conjugating
enzyme E2N
2 11% 98 gi|4507793 MS/MS
125 68,717 6.06 Villin 2 [Bos taurus] 28 41% 217 1.10E−16 gi|27806351 MALDI
126 86,014 5.76 Gelsolin 5 5% 161 gi|51854227 MS/MS
127 60,957 5.78 Similar to 60kDa heat
shock protein,
mitochondrial
precursor (Hsp60)
(60kDa chaperonin)
(CPN60) (heat shock
protein 60) (HSP-60)
15 31% 101 4.40E−05 gi|74005078 MALDI
127 58,423 7.96 Similar to LOC512571
protein [Bos taurus]
12 29% 75 0.019 gi|119902010 MALDI
128 49,978 7.01 Fumarate hydratase,
mitochondrial
(fumarase)
2 4% 111 gi|120604 MS/MS
129 32,030 7 Asparaginase-like 1
protein [Bos taurus]
5 14% 298 gi|116004289 MS/MS
131 41,144 6.46 Acetyl-coenzyme A
acetyltransferase 2 [Bos
taurus]
5 12% 206 gi|109659291 MS/MS
132 36,574 8.12 Lactate dehydrogenase
A [Bos taurus]
13 36% 138 9.10E−09 gi|27806559 MALDI
133 23,407 5.12 Rho GDP dissociation
inhibitor (GDI) alpha
[Bos taurus]
9 43% 106 1.40E−05 gi|28603774 MALDI
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Table 2 (Continued )
Spot
ID #
MW PI Protein ID aPeptides
matched
bSequence
coverage
cMowse
score
dExpected
value
NCBI Method
135 95,307 6.41 Eukaryotic translation
elongation factor 2 [Bos
taurus]
16 18% 129 7.20E−08 gi|115497900 MALDI
136 60,301 5.71 T-complex protein 1
subunit alpha
(TCP-1-alpha)
(CCT-alpha) (65kDa
antigen) Chinese
hamster
12 22% 94 0.00024 gi|135536 MALDI
137 61,389 8.62 Pyruvate kinase [Bos
taurus]
10 21% 85 0.0016 gi|73587283 MALDI
139 60,863 6.05 Chain A, crystal
structure of bovine
Hsc70(Aa1-
554)e213aD214A
mutant
14 27% 111 4.50E−06 gi|78101017 MALDI
140 43,702 6.09 Chain A, mitochondrial
Ef-Tu
14 38% 156 1.40E−10 gi|6137414 MALDI
142 50,456 5.94 GDP dissociation
inhibitor 2 [Bos taurus]
16 35% 155 1.80E−10 gi|76253900 MALDI
143 48,544 5.59 Proteasome (prosome,
macropain) 26S
subunit, ATPase 2
[Rattus norvegicus]
13 28% 80 0.0059 gi|15100181 MALDI
144 47,283 5.71 ARP3 actin-related
protein 3 homolog
(yeast) [Bos taurus]
10 21% 109 7.20E−06 gi|115304856 MALDI
146 46,353 4.31 Calreticulin, brain
isoform 1 [Bos taurus]
11 15% 103 4.31 gi|631545 MALDI
148 57,422 6.01 Chaperonin containing
TCP1, subunit 2 (beta)
[Rattus norvegicus]
14 35% 114 2.30E−06 gi|54400730 MALDI
149 50,122 6.02 Predicted: similar to
TIP49 [Bos taurus]
10 30% 79 0.0076 gi|119914925 MALDI
153 53,655 5.06 Vimentin [Mus
musculus]
31 64% 333 2.90E−28 gi|31982755 MALDI
155 36,594 6.8 Aldo-keto reductase
family 1, member A1
(aldehyde reductase)
[Bos taurus]
9 27% 108 9.10E−06 gi|115495641 MALDI
159 43,261 7.23 Psmc6 protein [Rattus
norvegicus]
12 37% 120 5.70E−07 gi|81294202 MALDI
160 38,075 7.14 Sorbitol
dehydrogenase [Bos
taurus]
6 24% 70 0.059 gi|82617550 MALDI
162 46,729 6.13 Isocitrate
dehydrogenase 1
(NADP+), soluble [Bos
taurus]
18 49% 148 9.10E−10 gi|75832090 MALDI
163 41,801 5.21 Chain A,
beta-actin–profilin
complex
10 32% 71 0.034 gi|576368 MALDI
166 29,802 5.57 Prohibitin [Mus
musculus]
8 36% 82 0.0038 gi|6679299 MALDI
171 59,707 8.22 Chain A, structure of
human muscle
pyruvate kinase
(Pkm2)
11 20% 77 0.012 gi|67464392 MALDI
172 58,423 7.96 Predicted: similar to
LOC512571 protein
[Bos taurus]
15 34% 98 8.70E−05 gi|119902010 MALDI
173 55,728 6.87 IMP (inosine
monophosphate)
dehydrogenase 2 [Bos
taurus]
15 31% 120 5.70E−07 gi|77735779 MALDI
175 35,509 9.77 TSH receptor
suppressor
element-binding
protein-1; TSEP-1
[Rattus sp.]
11 31% 71 0.031 gi|9653686 MALDI
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NCBI Method
178 38,214 6.13 Predicted: similar to
Glycerol-3-phosphate
dehydrogenase 1-like
[Bos taurus]
10 27% 92 0.00034 gi|119914253 MALDI
180 35,749 5.41 Chain A, crystal
structure of
phosphorylation-
mimicking mutant T6d
Of annexin IV
14 42% 128 9.10E−08 gi|14278334 MALDI
181 17,582 4.74 Predicted: similar to
tropomyosin 3 isoform
2 isoform 3 [Canis
familiaris]
14 52% 156 1.40E−10 gi|73961067 MALDI
216 17,351 5.92 PRDX5 protein [Bos
taurus]
9 50% 132 3.60E−08 gi|74354725 MALDI
218 16,220 5.87 Actin-related protein
2/3 complex, subunit 5,
16kDa [Bos taurus]
7 51% 88 0.00093 gi|78369476 MALDI
a Peptides matched refers to the number of peptides identified from the primary sequence.
b Sequence coverage refers to the percentage of the protein sequence represented by the matched peptides.
c MOWSE score is the absolute probability that the observed match is a random event expressed as −10× log10(P), where P is the absolute probability
(Pappin et al., 1993).
d The number of times one would expect to obtain an equal or higher score, purely by chance; analogous to P-value.
Fig. 3. Representative 2D-gel of trophectoderm cellular proteins from cell line NT30-11 with enumeration of the protein spots listed in Table 2.
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Fig. 4. Replicate 2D-gels runs (n=4) of the cellular proteins from cell
line NT2-16 at two passage levels and from frozen/thawed samples or
unfrozen samples.
There was no difference noted in the success rate of cell
line establishment from any of the sources of blastocysts,
except that the in vivo-derived blastocysts produced cell
lines with 100% efficiency, well above that of the IVP blas-
tocysts (Talbot et al., 2007a). However, the number of in
vivo blastocysts obtained was small in comparison to the
number of IVP blastocysts (Talbot et al., 2007a). In total,
16 NT-, 12 P-, 16 IVF- and 5 in vivo-derived cell lines were
compared by 2D-gel electrophoresis in the study. Details
of the origins of the NT cell lines are briefly summarized in
Table 1.
The proteins from the untreated, non-fractionated sam-
ples of each trophectoderm cell line, harvested from 1 T25
flask each, were separated by 2D-gel electrophoresis, e.g.,
Fig. 2, and the protein spots were analyzed and identi-
fied by mass spectroscopy (Table 2; Fig. 3). Fig. 2 shows
the 2D-gel protein profile of PT28-2, a parthenogenetic
blastocyst-derived trophectoderm cell line, and it is typ-
ical of all the cell lines. Because no more than 225g of
total protein could be loaded on a 7-cm IPG strip without
hampering the electrophoretic separation of the proteins
(Table2), is a compellationof themostabundant trophecto-
dermproteins that havebeen identified todate. Replication
of 2D-gel separations was observed in four independent
gel runs from two independent sample preparations of the
NT2-16 cell line (Fig. 4). Fig. 4 shows a close-up view of
the same area of the gels containing three principle spots;
annexin I (spot # 47), annexin II (spot # 41), and aldose
reductase (spot # 40). STO feeder cell protein was a minor
component of the total protein harvested from each T25
flask of the trophectoderm cell lines. That STO feeder cell
proteins are a minor proportion of the visible protein spots
is apparent from Fig. 2 which shows a 2D-gel where more
than 6 times as much sample from an STO feeder cell-
only T25 flask was electrophoretically separated (based on
equivalent trophectoderm cell line sample volume). Also,
data base species identification was often specific for cat-
tle but not cells of mice (STO cells are mouse fibroblasts,
Table 2). Extensive visual inspections of the gels were con-
ducted to see if any of the cellular proteins varied according
to the type of blastocyst the cell lines originated from and
this was confirmed by densitometry and 2D-gel-spot soft-
ware analysis. The comparison of the gels indicated two
proteins, identified as annexin I (spot # 47) and annexin
II (spot # 41), were different when comparing FT and P
cell lines to NT cell lines. A side-by-side comparison of the
portion of the gel containing the annexin I, annnexin II,
and aldose reductase proteins from the 16 NT-, 16 IVF-,
12 P-, and 5 in vivo-derived cell lines (VIVOT-) is shown
in Fig. 5. Annexin I content is clearly reduced in, or absent
from, the NT-derived cell lines in comparison to the IVF-,
parthenogenetic-, and in vivo-derived cell lines (designated
FT, PT, and VIVOT, respectively). Annexin II protein spots
were also reduced in theNT-derived cell lines although this
was not as apparent from visual inspection. Densitometry
measurements of the three proteins from all the gels ver-
ified that both annexins I and II were reduced (P≤0.05)
in the NT trophectoderm cell lines when compared to the
internal less variant control proteins, aldose reductase and
phosphoglycerate mutase (Fig. 6). The absolute values of
annexins I and II were not different (P≤0.05) between NT-
and in vivo-derived cell lines probably because of the small
sample size of VIVOT cell lines (n=5). However, by visual
inspection, 4 out of the 5 VIVOT cell lines had annexin I,
and 5 out of 5 had annexin II (Fig. 5). A difference (P≤0.05)
was found for annexin I when normalized to aldose reduc-
tase or phosphoglycerate mutase, two less variant proteins
(Fig. 6).
4. Discussion
Modulation of annexins, and also of S100 protein
family members that interact with some annexins, has
been observed in proteomic surveys of cow and pig NT
placentas and human placenta. Kim et al., 2005, found
down-regulation of annexin I in term NT placentas of cat-
tle when compared to normal control placentas. In 26-day
pig NT extraembryonic tissue, annexins I, II, and IV were
up-regulated in comparison to the extraembryonic tissue
from fetuses of normally bred sows (Chae et al., 2006). In
termpigNT placenta, proteomic analysis again showedup-
regulation of annexins I and IV (V and VIII, also) compared
to normal controls, but annexin IIwas down-regulated (Lee
et al., 2007). A few proteomic studies have investigated
human placental tissues, either from in vivo samples, or
in vitro samples from primary tissue cultures of cytotro-
phoblast cells as a model of trophectoderm differentiation
and function. In an in vitro differential oxygen model of
cytotrophoblast differentiation and invasion, Hoang et al.
(2001), found that the amount of annexin II in the cells
increased under hypoxic conditions. In another in vitro
study of human cytotrophoblast cells involving the mod-
eling of the role of neurokinin-B (NKB) in preeclampsia,
annexin II and the annexin I partner protein, S100A11
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Fig. 5. Side-by-side comparison of that portion of all the gels containing annexins I and II, and aldose reductase. NT cell lines designated GFP-CT were from
blastocysts expressing the GFP gene.
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Fig. 6. Comparison of the means of densitometry measurements of the proteins spots of annexins I and II, or when normalized to the densitometry of
aldose reductase and phosphoglycerate mutase, in 2D-gels of the proteins of NT-, FT-, PT-, and in vivo-derived (INV) bovine trophectoderm cell lines.
(calgizzarin; Streicher et al., 2009), were both down-
regulated in response to NKB treatment (Sawicki et al.,
2003). Annexin I binding partner, S100A11 protein, was
also found tobedown-regulated in theplacental villous tis-
sue ofwomen suffering from early loss of pregnancy (Liu et
al., 2006). Together, these previous proteomic studies and
results from the present research, associate annexins I and
II, and their S100 partner proteins, with pathophysiolog-
ical conditions or responses in the placenta and with NT
placentas.
Although the specific roles of annexins in thephysiology
of placentation and pregnancy are not well understood to
date, various studies draw attention to their involvement
in placental function and parturition (Myatt et al., 1992;
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Bogic et al., 1999). The location and function of annexins
have been studied mainly in human and rodent placen-
tas or in in vitro models thereof. The placenta is a rich
source of annexins, one study estimating that the annex-
ins make up 2% of the total placental membrane proteins
(Buhl et al., 1991), and annexins I and II can be readily
purified from placental tissue (Moore et al., 1992). Why
placental tissue contains so much and so many annexins is
also not understood. At least one annexin family member,
annexin V, is important to placental function and integrity,
and this appears to be due to its anti-coaggulation activ-
ity on the surface of the syncytiotrophoblast cells (Wang et
al., 1999). Annexins I and II are in greater amounts in the
amnion, chorion, and trophoblast cells (Myatt et al., 1992;
Kristoffersen and Matre, 1996; Sun et al., 1996; Bogic et al.,
1999). Annexin I, a/k/a lipocortin I, is a calcium-dependent
phospholipid-binding protein thatmay stimulate or inhibit
phospholipaseA2 (PLA2) and thus influence the production
of arachidonic acid and subsequently prostaglandin pro-
duction in the trophoblast and, possibly, the endometrium
through a potential paracrine mode of action (Bennett
et al., 1994; Aarli et al., 1997). Prostaglandin synthe-
sis, that can participate in an inflammatory response
or in a maternal “recognition of pregnancy” response
might, therefore, be influenced by annexin I in the peri-
implantation embryo’s trophoblast tissue (Lawrence et al.,
2002; Gavins et al., 2005; Meier et al., 2008). Also, annexin
II, a/k/a lipocortin II or calpactin I, is involved with PLA2
activity andprostaglandin synthesis through its interaction
with protein S100A10 (Wu et al., 1997; Akiba et al., 2000).
Potentially as important, however, is that annexin II in con-
junction with the S100A10 protein, has been identified as
the receptor for tissue plasminogen activator (tPA), and as
such, is involved in extracellular matrix (ECM) remodeling
viaactivationof cell surfaceboundplasminogen toplasmin,
and subsequently activation of matrix metaloproteinases
(Hajjar and Hamel, 1990; Bogic et al., 1999). Because ECM
remodeling and adjustments of cellular architecture are
important in establishing the intimate fetomaternal con-
nection in the placentomes of ruminants, down-regulation
of annexin II might lead to placentome failure in NT fetuses
(Hashizume et al., 2002; Hirata et al., 2003; Hoffert et al.,
2005; Pfarrer, 2006). Further, both annexins I and II directly
affect the migratory behavior of epithelial cells in several
cancer cell models, and down-regulation of these annex-
ins causes a loss of cell migration and “invasiveness”, as
measured by in vitro assay (Ling et al., 2004; Liu et al.,
2003; Babbin et al., 2006). So, again, it is possible that
down-regulation of annexins I and II in the trophoblast
of NT embryos hampers cotyledonary interaction with the
maternal caruncles due to inhibition of trophoblast cell-
mediated ECM remodeling and cell migratory processes
(Ling et al., 2004; Liu et al., 2003; Babbin et al., 2006).
Further investigations are necessary to confirm the
observation of the lesser amounts of annexins I and II
in the cultured trophectoderm cells of NT embryos. First,
because all of the NT trophectoderm cell lines in the study
were derived from NT embryos created with Jersey cat-
tle fetal fibroblasts (BFF-8 and BFF-10 nuclear donor cells;
see Powell et al., 2004 and Talbot et al., 2007a) further
comparative examinations are warranted. For example, NT
trophectoderm cell lines could be created with nuclear
donor cells from other cattle breeds and their protein
profiles similarly analyzed by 2D-gel electrophoresis. This
might identify if Jersey cattle trophectoderm cells are natu-
rally low in annexins I and II—although in the present study
theAI-derived trophectodermcell lineswere fromHolstein
cows inseminated with Jersey semen and all five had high
levels of annexin II and four of the five had high levels of
annexin I. Secondly, the analysis of NT trophectoderm cell
lines created from NT embryos made with donor nuclei
from several more independent fetal fibroblast cell lines
needs to be performed. This would clarify the possibility
that the down-regulation of annexin I and II genes might
only be associated with the use of certain nuclear donor
cell lines, or, by extension, certain cell types, e.g., fibroblast
compared to epithelial nuclear donor cells. Third, a com-
parison of annexins I and II in intact IVP embryos, ideally
NT and IVF embryos developed in vivo to the filamentous
stage and in comparison to matched AI embryos, needs to
be performed to ascertain that the down-regulated expres-
sion of annexins I and II observed in the in vitro-cultured
trophectoderm is also present in the in vivo trophectoderm
of the early peri-implantation embryo.
If the same aberration in annexins I and II levels is
observed with in vivo-developed trophectoderm tissue,
regardless of donor cell breed or embryo source, the annex-
insmight serveasmarkers formonitoringembryofitnessor
for monitoring modifications to NT methodology to make
NT embryos more fit, i.e., to see if aberrant annexin levels
could be changed to the “normal” levels of IVF embryos.
Because NT methodology will always be in vitro, the pro-
tein profile of in vitro-produced embryos that establish
pregnancies at “state of the art” efficiency, i.e., 40–50%,
is the appropriate comparative positive control. However,
differences in protein profile that can be elucidated in com-
parison to in vivo-derived embryos or embryonic tissuewill
always be of value in understanding basic developmental
biology and fetomaternal interaction. In any case, embryo
transfers of putatively “improved NT embryos” could then
test the assumption that NT embryos with IVF-like pro-
tein profileswill in fact have greater fitness for survival and
development to term.Also testedwouldbe themajor corol-
lary to this assumption that the protein profile at the early
blastocyst stage of development, prior to embryo transfer,
will be a good indicator of successful reprogramming for
later stages of development, i.e., will normal early gene
expression translate to normal gene expression during all
stages of development? The available literature does not
answer this question (Hashizume et al., 2002). Abnormal
proteins levels in NT embryos may also provide “mark-
ers” for the assessment of nuclear reprogramming that can
be used for the creation of rapid, non-destructive assays
of embryo fitness. Currently there are no real-time pro-
cedures for assessing whether a nuclear cloned embryo
is properly “reprogrammed” for normal developmental
gene expression prior to its transfer into the surrogate
mother. Immunocytochemical, anti-viral assay, or ELISA
based comparisons of individual NT, IVF, and P embryos
might be devised and tested for this purpose from genomic
and proteomic data, e.g., Kato et al. (2007) and Talbot et
al. (2008). Finally, the proteomic analysis of the trophec-
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toderm cell lines of cattle, as it continues, will develop
a database from which comparative analyses can be per-
formed from other related proteomic and genomic studies
to broaden the fundamental knowledge of developmental
biology and reproductive physiology.
The 2D-gel electrophoresis of the total thiourea/urea
extracted cellular proteins of the trophectoderm cell lines
resolved protein spots representing the most abundant
proteins in the crude cell lysate. To identify the many
thousands of proteins that must actually comprise the cell
lysates, fractionation of the total cell lysate (or the use of
subcellular organelle preparations) must be done to dras-
tically reduce the percentage content of proteins such as
actin andcytokeratin-8,which, becauseof their abundance,
preclude loading enough protein on the IPG strips to see
the less abundant proteins. From 149 spots selected and
analyzed by mass spectroscopy, 104 unique proteins were
identified. Some of the protein spots that were analyzed
contained mixtures of proteins and will require greater
electrophoretic resolution in one or both dimensions to
resolve. Also, some were not identifiable in the protein
data bases, but the data bases are always improving over
time. In any case, many of the proteins were in common
with those reported in proteomic analyses of the in vivo
tissues of ungulate NT placentas and of human placen-
tas or cytotrophoblast cells (Hoang et al., 2001; Sawicki et
al., 2003; Kim et al., 2005; Lee et al., 2007; Zhang et al.,
2008). As discussed above, annexins I and II were found in
the samples of trophectoderm cell lines, but also, annexins
V and VIII were found. Proteins found the most fre-
quently represented metabolic/cytosolic enzymes such as
lactate dehydrogenase, creatine kinase, aldose reductase,
phosphoglycerate mutase, enolase, triosephosphate iso-
merase, carbonic anhydrase, glyceraldehyde-3-phosphate
dehydrogenase, aldehyde reductase, triosephosphate iso-
merase, and transketolase. The most abundant proteins
were cytoskeletal proteins such as actin, tubulin, myosin,
cytokeratin-8, -9, -18, and -19, and cytoskeletal interacting
proteins such as tropomyosin, profilin, villin, cofilin, gel-
solin, transgelin and stratifin. The intermediate filament
protein, vimitin, was also found but was species identi-
fied as Mus musculus, and, therefore, was probably from
the STO feeder cell protein component of the cell lysate.
Chaperone or stress proteins such as heat shock proteins
and TCP1 subunit 2 were found, and anti-oxidant proteins
such as peroxiredoxin 1, peroxiredoxin 5, anti-oxidant
protein 2, and glutathione-S-transferase were present.
Finally, protein-degradation proteins such as proteasome
26S subunit and ubiquitin-conjugating enzyme E2 were
represented, a calcium-binding protein, calreticulin, was
found, and voltage-dependent anion channel 1 and 2 pro-
teins were found.
In conclusion, the majority of NT pregnancies in cat-
tle are lost around the time of placentation and placental
abnormalities are frequently associated with NT pregnan-
cies (De Sousa et al., 2001; Hill et al., 2002; Hashizume
et al., 2002; Powell et al., 2004; Chae et al., 2006; Arnold
et al., 2006). An 18-day NT embryo–maternal interaction,
i.e., during the early implantation stage, had abnormalities
in the endometrial tissue that were already measurable in
terms of endometrial mRNA responses (Bauersachs et al.,
2009)—so what is the NT conceptus doing or not doing
to cause this? Aberrant expression of annexin proteins
are probably pertinent to this question since they are
abundant in the placenta, specifically at the fetomaternal
interface (Myatt et al., 1992; Kristoffersen andMatre, 1996;
Bogic et al., 1999), and because annexins, or their biolog-
ically active externalized soluble peptide fragments, have
effects on so many diverse biological processes, including
tissue immunomodulation, apoptosis (annexin V), inhibi-
tion of placental blood coagulation (annexin V), mediation
of intracellular membrane fusion (annexins I and II and
synexin or annexin VII), signal transduction for cell dif-
ferentiation, extracellularmatrix remodeling via activation
of plasminogen and, indirectly, matrix metalloproteinases
(MMPs), and prostaglandin synthesis regulation via high
affinity, Ca2+-dependent, binding of phospholipids (Creutz,
2003; Buckland and Wilton, 2003).
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